Vault-13

OUP Management Co., LLC

Bala Cynwyd, PA · CIK 1880124 · 13F filing filed 2023-11-09

No investment adviser registration (Form ADV) found for this filer. It may be a parent company whose subsidiaries are the registered advisers, a bank or insurer, or a manager based outside the US.

$44.5m reported value -24.2% vs Q2 2023
12positions
99.6%in top 10
1 new 0 added 0 reduced 1 sold out vs Q2 2023

Holdings, Q3 2023

The small lines show how much was held over the last 4 quarters (adjusted for stock splits).

#SecurityTickerShares Value% of portfolioChangeShares change
1 CENTESSA PHARMACEUTICALS PLC SPONSORED ADS SPONSORED ADS 2,937,615 $19.0m42.74% 42.74% UnchangedShares held: Q4 2022 2.9m, Q1 2023 2.9m, Q2 2023 2.9m, Q3 2023 2.9m
2 AEROVATE THERAPEUTICS INC COM COM 603,762 $8.2m18.43% 18.43% UnchangedShares held: Q4 2022 603.8k, Q1 2023 603.8k, Q2 2023 603.8k, Q3 2023 603.8k
3 CYTEIR THERAPEUTICS INC COM COM 2,459,572 $7.0m15.71% 15.71% UnchangedShares held: Q4 2022 2.5m, Q1 2023 2.5m, Q2 2023 2.5m, Q3 2023 2.5m
4 PMV PHARMACEUTICALS INC COM PMVP PMVP 989,232 $6.1m13.66% 13.66% UnchangedShares held: Q4 2022 989.2k, Q1 2023 989.2k, Q2 2023 989.2k, Q3 2023 989.2k
5 GRAPHITE BIO INC COM GRPH GRPH 406,308 $1.0m2.27% 2.27% UnchangedShares held: Q4 2022 406.3k, Q1 2023 406.3k, Q2 2023 406.3k, Q3 2023 406.3k
6 SELECTA BIOSCIENCES INC COM COM 862,543 $914.3k2.06% 2.06% UnchangedShares held: Q4 2022 862.5k, Q1 2023 862.5k, Q2 2023 862.5k, Q3 2023 862.5k
7 VOR BIOPHARMA INC COM COM 374,714 $794.4k1.79% 1.79% UnchangedShares held: Q4 2022 374.7k, Q1 2023 374.7k, Q2 2023 374.7k, Q3 2023 374.7k
8 EFFECTOR THERAPEUTICS INC COM COM 1,025,697 $615.3k1.38% 1.38% UnchangedShares held: Q4 2022 1.0m, Q1 2023 1.0m, Q2 2023 1.0m, Q3 2023 1.0m
9 PRECISION BIOSCIENCES INC COM COM 1,123,913 $383.6k0.86% 0.86% UnchangedShares held: Q4 2022 1.1m, Q1 2023 1.1m, Q2 2023 1.1m, Q3 2023 1.1m
10 SPERO THERAPEUTICS INC COM SPRO SPRO 249,070 $301.4k0.68% 0.68% UnchangedShares held: Q4 2022 249.1k, Q1 2023 249.1k, Q2 2023 249.1k, Q3 2023 249.1k
11 IKENA ONCOLOGY INC COM COM 26,833 $116.2k0.26% 0.26% NewShares held: Q4 2022 0, Q1 2023 0, Q2 2023 0, Q3 2023 26.8k
12 HOMOLOGY MEDICINES INC COM FIXX FIXX 64,000 $74.9k0.17% 0.17% UnchangedShares held: Q4 2022 64.0k, Q1 2023 64.0k, Q2 2023 64.0k, Q3 2023 64.0k

Sold out since Q2 2023

SecurityTickerShares held beforeValue then
DICE THERAPEUTICS INC 268,346 $12.5m268.3k shares